Your browser doesn't support javascript.
loading
Verapamil attenuates the malignant treatment course in recurrent status epilepticus.
Schmitt, Friedhelm C; Dehnicke, Christoph; Merschhemke, Martin; Meencke, Heinz-Joachim.
Affiliation
  • Schmitt FC; University Otto-von-Guericke, University Hospital for Neurology, Magdeburg, Germany. FC.Schmitt@gmx.net
Epilepsy Behav ; 17(4): 565-8, 2010 Apr.
Article in En | MEDLINE | ID: mdl-20189886
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Calcium Channel Blockers / Verapamil Type of study: Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Epilepsy Behav Journal subject: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Year: 2010 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Calcium Channel Blockers / Verapamil Type of study: Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Epilepsy Behav Journal subject: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Year: 2010 Document type: Article Affiliation country: Germany Country of publication: United States